Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib

Barrientos, JC, Burger, JA, Byrd, JC et al. (5 more authors) (2019) Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib. Leukemia & Lymphoma, 60 (4). pp. 1000-1005. ISSN 1042-8194

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Keywords: Ibrutinib; Bruton’s tyrosine kinase inhibitor; chronic lymphocytic leukemia; small lymphocytic lymphoma; lymphocytosis
Dates:
  • Published: 21 March 2019
  • Accepted: 9 August 2018
  • Published (online): 2 October 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Jan 2019 13:46
Last Modified: 08 May 2019 10:58
Status: Published
Publisher: Taylor & Francis
Identification Number: https://doi.org/10.1080/10428194.2018.1512710

Download

Share / Export

Statistics